肾康注射液治疗慢性肾功能衰竭的临床分析

A clinical analysis of treating chronic renal failure with the Shenkang injection

目的:评价慢性肾功能衰竭治疗中应用肾康注射液的价值。方法:选择2014-2017年收治住院的慢性肾功能衰竭患者,接受常规治疗+肾衰宁片治疗的26例患者作为对照组、加行肾康注射液治疗的26例患者作为实验组。对比两组慢性肾功能衰竭患者的治疗效果以及治疗期间的血肌酐(SCr)、血尿素氮(BUN)、血清胱抑素(Cys C)情况。结果:治疗前两组慢性肾功能衰竭患者组间SCr、Cys C、BUN结果对比,P>0.05,差异无统计学意义。治疗后,SCr、Cys C、BUN结果对比,P<0.05,实验组优于对照组。另外,实验组慢性肾功能衰竭患者治疗总有效率高于对照组,P<0.05。结论:常规治疗的基础上加行肾康注射液治疗慢性肾功能衰竭肾功能改善明显、整体疗效显著,具有实施优势。

Objective:To investigate efficacy of the Shenkang injection(肾康注射液)on chronic renal failure.Methods:26 patients were given conventional treatment plus the Shenshuaining tablets(肾衰宁片)as the control group;and 26 patients were given the Shenkang injection as the experimental group.Efficacy,SCr,BUN and CysC in two groups were compared.Results:After treatment,efficacy,SCr,BUN and CysC in the experimental group were better,P<0.05.Conclusion:The Shenkang injection on chronic renal failure shows a good effect.